USP10 and acute myeloid leukemia: *USP10 stabilises oncogenic FLT3‐ITD in AML [24]. *USP10 deubiquitinates and stabilises SKP2 enhancing the growth of CML xenografts in vivo [25]. *USP10 deubiquitinates and stabilises the tyrosine kinase SYK promoting the proliferation of SYK‐driven AML cells [26].